On May 20, 2024, Accelerate Diagnostics, Inc. closed the transaction. The company has now issued 2,716,763 units at a price of $1.73 per unit for the gross proceeds of $4,699,999.99 in the transaction. The company has issued 1,156,069 Units at a price of $1.73 per unit for gross proceeds of $2,700,000.62 in its second and final tranche closing.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.265 USD | +9.05% |
|
-3.73% | -67.09% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-67.09% | 27.39M | |
+4.62% | 217B | |
+7.78% | 191B | |
+28.10% | 154B | |
+32.76% | 112B | |
+1.22% | 62.75B | |
+17.05% | 53.34B | |
+1.45% | 48.88B | |
-3.59% | 39.36B | |
+3.50% | 35.73B |
- Stock Market
- Equities
- AXDX Stock
- News Accelerate Diagnostics, Inc.
- Accelerate Diagnostics, Inc. announced that it has received $4.7 million in funding from Jack W. Schuler Living Trust